The compound 2-bromopropane possesses reproductive toxicity in male and female humans 1, 2) . We showed that an injection of 2-bromopropane or exposure to 1,2-dichloropropane significantly decreased the number of spontaneously ovulated ova and delayed estrous cycle in female F344 rats 3, 4) . The number of ovulated ova during superovulation induced by equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG) in mice is significantly reduced by 2-bromopropane 5) . Thus, ovulation is a significant marker that can be used to detect reproductive toxicity in female animals. Some studies have examined the influence of chemicals on the murine ovary in vivo and in vitro by using ovulation induced by eCG and hCG in immature female rats [6] [7] [8] [9] .
Introduction
The compound 2-bromopropane possesses reproductive toxicity in male and female humans 1, 2) . We showed that an injection of 2-bromopropane or exposure to 1,2-dichloropropane significantly decreased the number of spontaneously ovulated ova and delayed estrous cycle in female F344 rats 3, 4) . The number of ovulated ova during superovulation induced by equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG) in mice is significantly reduced by 2-bromopropane 5) . Thus, ovulation is a significant marker that can be used to detect reproductive toxicity in female animals. Some studies have examined the influence of chemicals on the murine ovary in vivo and in vitro by using ovulation induced by eCG and hCG in immature female rats [6] [7] [8] [9] .
Di-(2-ethylhexyl) phthalate (DEHP) is generally used as plasticizer of vinyl products, and it exhibits ovarian toxicity after short-term administration in rats. A study in vivo by Davis et al. 10) showed that consecutive daily doses of 2,000 mg/kg of DEHP suppressed or delayed ovulation with a concomitant significant decrease in serum estradiol-17 β (E 2 ). A study in vitro found that mono-(2-ethylhexyl) phthalate (MEHP), an active metabolite of DEHP, decreases the levels of E 2 converted from testosterone (T) in incubation medium 11) , and also those of mRNA for aromatase that synthesizes E 2 from T 12) . These finding suggest that the inhibiting effect on ovulation is caused by suppression of E 2 synthesis. In view of the suppressive effect of DEHP on E 2 synthesis, induced ovulation in immature female rats is useful for studying the ovarian toxicity of DEHP.
DEHP is also known to suppress enzyme activity in the liver of rats 13, 14) . When fed with diets containing DEHP, the serum thyroxine (T 4 ) levels declined to about half of those of control rats 3 d after the initiation of intake of DEHP in diet 13) . Administration of T 4 to intact and thyroidectomized rats significantly increased the circulating levels of thyroid hormones, and the increase of thyroid hormone levels was suppressed by DEHP administered simultaneously with T 4 14) . These results suggest that the consumption of circulating levels of thyroid hormones is accelerated by DEHP through stimulating the metabolism and/or excretion of thyroid hormones in the liver. Moreover, Tamura et al. reported that in thyroidectomized rats treated with eCG and hCG, the number of ova in induced ovulation and ovarian hormone levels were significantly increased compared with those in intact rats treated with eCG and hCG 15) . They suggested that thyroid hormone plays an inhibitory role in ovarian hormone synthesis and follicular development induced by eCG injection in immature female rats. The above mentioned findings seem to suggest the possibility that DEHP affects induced ovulation in immature rats through thyroid homeostasis.
In our previous study, subcutaneous injections of 500 mg/kg of DEHP administered to immature F344 rats tended to suppress superovulation induced by a single injection of eCG 16) . In the present study, in order to determine the exact effects of DEHP on reproductive function, the ability of eCG and hCG to induce superovulation in DEHP-treated rats was estimated, and we also investigated whether thyroid hormone is involved in the ovarian toxicity of DEHP.
Materials and methods

Animals and experimental designs
Intact immature females (intact females) of F344/DuCrj strain (F344) rat purchased from Charles River Japan, Inc. at 21 d of age were housed under conditions of 12 h light (08:00 to 20:00)/12 h darkness, with room temperature maintained at 23 1˚C and 55 5 % humidity. Sterilized pellet food, CE-2, purchased from Clea Japan, Inc. and water were freely available. Immature F344 rat females hypophysectomized at 24 d of age at the Technical Center of Charles River Japan, Inc. (hypox females) were purchased at 27 d of age. The hypophysectomy was performed by the parapharyngeal method because this method was expected to be more successful than the intra-aural method. Rats were anesthetized by an intraperitoneal injection of ketamine/xylazine. The complete sucking out of the pituitary was confirmed by the degree of body weight increase after the operation. Rats were handled according to the Animal Welfare. At the end of the experiment, the removal of the gland was verified anatomically.
The animals were housed under the same breeding conditions as intact females. Doses of 125, 250, 500, 1,000 or 2,000 mg/kg body weight (B.W.) of DEHP (Wako Pure Chemical Industries, Ltd., Japan) were diluted in olive oil (Wako). The final volume of olive oil containing each of the above doses was adjusted to 3 ml. In the first experiment, intact and hypox females were subcutaneously (sc) injected with DEHP at the above doses at intervals of 24 h from 24 to 27 d of age and from 27 to 30 d of age, respectively. In the second experiment, DEHP at 500 or 2,000 mg/kg was administered at 24-h intervals for one to three days during the four days between 24 and 27 d of age. Superovulation was induced with eCG (Teikoku Hormone MSG. Co., Ltd., Japan) at a dose of 15 iu in 0.15 ml saline injected intramuscularly (im) at 25 d of age to intact females and at 28 d of age to hypox females followed by 15 iu hCG (Teikoku Hormone) in 0.15 ml saline injected intraperitoneally (ip) at 27 or 30 d of age, 56 or 72 h after the eCG injection. All rats were sacrificed by decapitation at 28 or 31 d of age, at 72 h after the eCG injection 16) , and the ovaries and uteri were weighed after removing the fat and connective tissue. Ova shed into oviducts were collected and counted 16) . Briefly, ovulated ova were flushed with physiological saline delivered from a 2.5 ml syringe attached to a 27G 3/4 needle. Ova enveloped by cumulus cells were put into 0.1% (359 units/ml) hyaluronidase (Sigma Chemical Co., USA). The cumulus cells were dispersed at 37˚C on a warm plate and removed from the ova, which were then counted under a light microscope. We defined superovulation as ovulation in which the number of ovulated ova was more than 11 16) .
Hormone measurements
Trunk blood released by decapitation was collected in conical tubes and immediately placed on ice. The tubes were centrifuged at 1,630 g at 4˚C for 15 min, and the serum was separated and stored at 80˚C. Concentrations of T 4 in serum were measured using DELFIA kits (PerkinElmer Life Sciences Japan Co., Ltd.) in a time-resolved fluorometric assay. The intra-and inter-assay coefficients of variation for the T 4 assay were 7.03 and 4.74 %, respectively.
Statistical analysis
Data were analyzed by use of one-way analysis of variance (ANOVA) followed by Duncan's multiple comparison test and Fisher's exact probability tests. Table 1 shows the effects of 4 consecutive injections of DEHP on reproductive development in intact immature rats with induced superovulation. The number of control and DEHP-treated rats in which ovulation and superovulation were induced did not differ. A significant change was noted only in the number of ovulated ova in the 500 mg DEHP-treated groups (Table 1) . Among rats in which superovulation was induced, the mean numbers of ovulated ova in control, 125 and 2,000 mg DEHP groups were 48.9, 51.6 and 51.3, respectively. The mean numbers in 250 mg DEHP group (43.9 ova) and in 1000 mg DEHP group (39.8 ova) were less than that of the control group. The mean number (30.5) of ovulated ova in rats treated with 500 mg DEHP was significantly decreased (P<0.05) compared with control and 125 and 2,000 mg DEHPtreated rats (Table 1) . Table 2 compares the effects of 500 or 2,000 mg DEHP injections on ovulation induced by 15 iu each of eCG and hCG in hypox and intact rats. When treated with olive oil alone, ovulation was induced in 4 of 8 hypox rats, and in all intact rats injected with eCG and hCG at a 56 h interval. The difference between the two groups was significant (50% vs. 100%; P<0.05). When injected with eCG and hCG at a 72 h interval, ovulation was induced in 7 of 8 hypox rats, and this ratio (87.5%) was not significantly different from that of intact rats at the 56 h interval. The numbers of rats treated with 500 or 2,000 mg DEHP and exhibiting ovulation by eCG and hCG did not significantly differ between intact and hypox rats ( Table 2) . We counted the numbers of rats that underwent superovulation and then calculated the ratios of superovulation to ovulation. The superovulation ratios did not significantly differ among the control, 500 and 2,000 mg/kg intact and hypox groups. The mean number of ovulated ova was counted only in the superovulated rats. The mean numbers of ovulated ova in the intact and hypox groups treated with olive oil and given eCG and hCG at a 56 h interval were 48.9 and 28.3, respectively, and 35.0 in the hypox group given eCG and hCG at a 72 h interval. These differences in numbers of ova obtained were significant (P<0.05). The mean numbers of ovulated ova after the administration of 2,000 mg DEHP were 51.3 in the intact group, and 31.2 and 31.0 in each of the hypox groups. The differences were statistically significant between the intact and the two hypox groups (P<0.05). On the other hand, the mean numbers of ovulated ova after the administration of 500 mg DEHP were 30.5 in the intact group, and 26.1 and 26.2 in each of the hypox groups (no significant differences among the three groups; Table 2 ). Table 3 shows how the timing of the 500 and 2,000 mg DEHP injections affected the ovulation induced by eCG and hCG. The numbers of control and DEHP-treated rats that ovulated or superovulated were almost constant regardless of injection time or dose of DEHP. The mean number of superovulated ova was not influenced by the time of DEHP injection, and the number of ovulated ova between control and 2,000 mg DEHP-treated groups did not significantly differ. Although the mean number of ovulated ova in 500 mg DEHP-treated rats tended to decrease depending on the total amount of injected DEHP, differences between control and the 500 mg DEHP-treated groups were not statistically significant (Table 3) . Figure 1 shows the concentrations of T 4 in superovulated intact (A) and hypox rats (B). The T 4 concentration (61.5 6.5 ng/ml) of intact rats treated with 500 mg DEHP was almost equal to that (67.4 6.2 ng/ml) of the control group, and that (41.3 4.5 ng/ml) of the 2,000 mg DEHP group was significantly lower (P<0.05) than the control (Fig. 1A) . The mean T 4 concentrations of the two hypox groups were determined by adding the results from these groups regardless of eCG-hCG intervals because the T 4 values did not differ between them. The T 4 concentration (24.1 2.9 ng/ml) of the hypox group treated with 500 mg DEHP did not significantly vary from that (26. 6 2.9 ng/ml) of the control group without DEHP. The T 4 concentration (21.4 1.1 ng/ml) of the group treated with 2,000 mg DEHP was 20 % lower than that of the control (Fig. 1B) .
Results
Ovulation
Hormonal changes
Discussion
The results of the present study indicated that daily sc injections of 500 mg DEHP for 4 successive days suppressed the ovulation induced by eCG-hCG injection in immature F344 rats. The mean numbers of ovulated ova in groups treated with DEHP other than at 500 mg did not show obvious decrease from that of the control group ( Table 1 ). The numbers of superovulated ova in all groups given 1 to 3 injections of 500 mg DEHP were not significantly lower than that of the control (Table 3) , suggesting that a total amount of 2,000 mg/kg of DEHP received over 4 d is required to decrease the number of ova during superovulation. However, 1 to 4 injections of 2,000 mg DEHP failed to inhibit superovulation (Tables  1 and 3 ), suggesting that the effect which suppressed the number of ovulated ova in 500 mg DEHP-treated rats was revoked by the administration of 2,000 mg DEHP. It is generally thought that DEHP inhibits E 2 synthesis in vivo 10) and in vitro 11, 12) . Although 500 mg DEHP did not affect the induction ratio of ovulation (Table 1) , this dose of DEHP for 4 successive days decreased the number of ovulated ova. A possible explanation for this phenomenon is that a dose of 500 mg DEHP for 4 successive days inhibits the growth of ovarian follicles from the primordial to the ovulable follicle. If the decreased number of ovulated ova in 500 mg DEHP-treated rats was induced by the toxicity of MEHP through suppressed estradiol synthesis, then the absence of such an effect at 2,000 mg DEHP on the number of ovulated ova would be unexplained, since this dose of DEHP should produce high peripheral levels of MEHP through metabolism.
In hypox rats, the numbers of ovulated ova in both the control and 2000 mg DEHP groups were decreased compared with those of intact rats. This result means that endogenous gonadotropic hormones (GTHs) secreted from the pituitary were involved in the superovulation in intact rats (Table 2) . However, the mean numbers of ovulated ova did not significantly differ between intact and hypox rats in the 500 mg DEHP groups ( Table 2 ). The injection of 500 mg DEHP for 4 successive days seemed to mimic the effect of hypophysectomy, which interrupts the hormonal effects on follicular growth in the hypothalamic-pituitary-ovarian axis. To investigate the cause of the absence of dose-dependency in the inhibitory effect of 500 mg DEHP on the ovulation, we examined the involvement of the thyroid hormone. Tamura et al. 15) showed the role of thyroid hormone in the onset of puberty by using hormone-induced ovulation in immature female rats. In female rats thyroidectomized before puberty and treated with eCG, the serum estradiol and THYROXINE AND OVARIAN TOXICITY OF DEHP 277 2) Relative weights of ovary were calculated as absolute ovary weight (mg)/body weight ( g ) on the day of autopsy.
3) Uterus weights were measured after uterus fluid was blotted. Relative uterus weights were calculated as blotted weight (mg) of uterus/body weight ( g ) on the day of autopsy. 2) The number of rats that showed ovulation, and values in parentheses indicate the ovulation ratio (rats showing ovulation/rats used). # indicates significant difference from intact group (P<0.05) by Fisher's exact probability test. 3) The number of rats that showed superovulation, and values in parentheses indicate the superovulation ratio by rat numbers (superovulation/ovulation). 4) The values are means SEM; different letter of superscripts indicate significant difference (P<0.05 by Duncan's multiple comparison test) within the column on the same treatment of DEHP.
inhibin levels were elevated, and the number of large healthy follicles (>400 µm in diameter) was increased as compared with intact rats. When T 4 was administered to thyroidectomized rats, the increases in the hormone levels and in the number of developed follicles were suppressed at levels equating those of intact rats. Circulating levels of thyroid hormone were obviously low in the rats receiving DEHP 13, 14) , and in our present study, the serum T 4 level was significantly lowered by treatment with 2,000 mg DEHP (P<0.05) in intact rats, whereas the T 4 level tended to be decreased by 2,000 mg DEHP in hypox rats, although the decrease was without statistical significance (Fig. 1) . These results are consistent with the hypothesis that the inhibitory effects of thyroid hormone on the follicular growth were revoked by 2,000 mg DEHP through the consumption of circulating thyroid hormone. Factors other than serum T 4 level may be involved in the revocation of DEHP effects at 2,000 mg/kg on the ovulation, because basal levels of serum T 4 were lowered in hypox rats. However, the differences in T 4 levels between control and 2,000 mg/kg groups strongly suggest the role of T 4 in the regulation of ovulation. It is generally known that E 2 is required for follicular growth in the ovary. Also DEHP is well known to suppress E 2 synthesis in vivo and in vitro. Thus, the inhibitory effect of 500 mg DEHP on superovulation found in the present study may have been caused by the disruption of ovarian hormonal relationships. However, 2,000 mg of DEHP seemed to revoke this inhibitory effect of DEHP by decreasing the serum T 4 level. We suggest that the thyroid hormone plays an important role in follicular development and ovulation. All rats in control and DEHP-treated groups were injected sc with daily doses of olive oil and DEHP solution, respectively. All injections were initiated 24 h before eCG treatment, and thereafter were conducted at intervals of 24 h. 1) Numerator and denominator indicate the number of rats that showed ovulation and the number of rats used, respectively. The values in parentheses indicate the ovulation ratio (rats showing ovulation/rats used).
2) The number of rats that showed superovulation, and the values in parentheses indicate the superovulation ratio by rat numbers (superovulation/ovulation). 3) Means SEM of ovulated ova in rats with superovulation. 
